Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001231540 | SCV001404066 | uncertain significance | Charcot-Marie-Tooth disease, type I | 2023-06-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. This sequence change affects codon 78 of the MPZ mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MPZ protein. This variant also falls at the last nucleotide of exon 2, which is part of the consensus splice site for this exon. This variant is present in population databases (rs368149365, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with MPZ-related conditions. ClinVar contains an entry for this variant (Variation ID: 958383). |
Baylor Genetics | RCV001329968 | SCV001521543 | uncertain significance | Dejerine-Sottas disease | 2020-02-07 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002447158 | SCV002732669 | likely benign | Inborn genetic diseases | 2020-11-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Uffe Birk Jensen Lab, |
RCV003482910 | SCV004012844 | uncertain significance | Charcot-Marie-Tooth disease type 1B | 2023-07-10 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV003482910 | SCV004804704 | uncertain significance | Charcot-Marie-Tooth disease type 1B | 2024-03-17 | criteria provided, single submitter | research |